DuPont Ready to Share Ideas at Live Bioprocessing Event
WILMINGTON, Del., Nov. 5, 2021, – DuPont Water Solutions (DWS) will be attending TIDES Europe – a face-to-face Event at Sheraton Airport Brussels from November 15, 2021. The event is a forum designed specifically for oligonucleotide and peptide leaders to help expedite therapeutics to market, improve CMC (chemistry, manufacturing and controls) efficiency and build new partnerships. The event gives access to new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies- from discovery to market, with an emphasis on the European region.
During the event, Sophie Corbet, TS&D Manager Bioprocessing at DuPont Water Solutions, will present a poster illustrating the ability of DuPont™ AmberChrom™ Chromatography Resins to purify oligonucleotides. Oligonucleotides are short synthetic DNA sequences that are designed to recognize target DNA sites for diagnostic or therapeutic purposes.
Ajay Kumar Singh, EMEA Technical Sales & Market Development Leader, Bioprocessing says, “DuPont scientists work alongside our global partners to develop solutions for the emerging challenges within the rapidly evolving oligonucleotide market. The production of high-purity therapeutics is only possible thanks to downstream purification processes, ensuring they meet strict safety and efficacy standards. Technology from DuPont is easing the complex purification process, which is often made difficult by impurities that closely resemble the target molecules. TIDES Europe is a fantastic opportunity to connect with researchers and drug manufacturers and we’re very pleased to be able to have a physical presence at this key industry event. Our experts look forward to meeting with delegates and discussing how polymeric resins from DuPont can solve difficult purification challenges, from benchtop discovery through commercial-scale manufacturing.”
TIDES Europe is being delivered in person November 15-16 and will showcase digitally all of the content from the live event with additional keynotes, panel discussions and meeting scheduling to be fully inclusive to those unable to attend in person.
Since the 1950s, DuPont has been developing solutions to address complicated separations and purifications. As a global market leader in adsorbents and ion exchange resins, DuPont Water Solutions offers a broad range of products specifically designed to be used in bioprocessing and drug synthesis, from advanced gene therapies to conventional small molecule APIs, and virus test kits. With a Wellness Optimized World at our core, our global research and development skills and manufacturing capabilities can help enable drug manufacturers to deliver diagnostic and therapeutic solutions, both now and in the future, resulting in better outcomes for patients and life science companies alike.
Continuous investment in manufacturing excellence and innovation combined with DuPont’s global R&D capabilities and expertise enable our products to address specific conditions and requirements for the food & beverage, dietary supplement, pharmaceutical excipient, API, and bioprocessing industries. Our high-quality brands, such as DuPont™ AmberLite™, DuPont™ AmberChrom™, DuPont™ Duolite™ and FilmTec™ are well established and recognized across the Life Sciences Industries.
About DuPont
DuPont (NYSE:DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.